|国家预印本平台
首页|重组肿瘤导向肽RGD-白喉毒素DT390融合蛋白的原核表达及鉴定

重组肿瘤导向肽RGD-白喉毒素DT390融合蛋白的原核表达及鉴定

loning, Expression and Identify of Recombinant Tumor Homing Peptide RGD- diphtheria toxin (DT390) Fusion Protein

中文摘要英文摘要

目的:构建RGD短肽与白喉毒素DT390的重组原核表达载体,并进行重组蛋白的表达及鉴定。方法:利用PCR技术,构建RGD与白喉毒素的酶活性区和跨膜转运区(N端386-391个氨基酸,DT390)的融合基因,并将该DNA片段克隆到原核表达载体pET-28a中。重组质粒转化大肠杆菌BL21(DE3)plysS,并进行诱导表达,获得重组蛋白,表达产物经Western blot进行鉴定。结果:扩增产物与预期大小相符合,重组质粒经双酶切鉴定及基因序列测定表明构建正确;诱导后融合蛋白经SDS-PAGE和Western blot检测到分子量约为46 000的特异性蛋白条带。结论:构建了RGD-DT390/pET-28a原核表达载体,并进行了重组蛋白的表达及鉴定,从而为进一步研究导向肽对恶性肿瘤的靶向性治疗奠定了基础。

Purpose: To construct the recombinant vector of the fused gene (RGD-DT390) of RGD and truncated diphtheria toxin gene (DT390), express in E.Coli and identify the target protein in vitro. Methods: The fused gene (RGD-DT390) was amplified by PCR, and was inserted into pET28a vector. The recombinant plasmid pET-28a- RGD- DT390 was expressed in E.coli BL21 (DE3) plysS under the induction of IPTG. The fusion protein was identify by SDS-PAGE and Western blot. Results: After induced by IPTG, an extra protein band appeared near the 46KD, more than 20% of the total bacterial protein. Western bloting showed that the recombinant protein could react specifically with a mouse monoclonal antibody against HIS. The expression target accumulates as inclusion bodies. Conclusion: The experiment method provided by this paper can help extract soluble protein RGD- DT390, which will lay a foundation for the research of tumor molecular targeted therapy.

马丁、张逸群、马湘一、叶双梅

肿瘤学生物工程学分子生物学

RGD白喉毒素DT390融合蛋白表达

RGDDT390fusion proteinexpression

马丁,张逸群,马湘一,叶双梅.重组肿瘤导向肽RGD-白喉毒素DT390融合蛋白的原核表达及鉴定[EB/OL].(2012-06-05)[2025-08-04].http://www.paper.edu.cn/releasepaper/content/201206-72.点此复制

评论